基于年龄-时期-队列模型分析1990—2019年中国胆道癌死亡趋势的研究

doi:10.11904/j.issn.1002-3070.2022.04.002

摘要/Abstract

摘要： 目的基于年龄-时期-队列模型分析中国1990—2019年胆道癌死亡趋势,为胆道癌的防控提供科学依据。方法基于2019年全球疾病负担(Global burden of disease,GBD)中1990—2019年20~84岁中国居民胆道癌的死亡数据,运用年龄-时期-队列(Age-period-cohort,APC)模型分析年龄、时期和队列对胆道癌死亡率变化的影响。结果 1990—2019年中国胆道癌死亡率呈上升趋势,2019年死亡率增加至2.42/10万,男性和女性死亡率分别增加至2.45/10万和2.39/10万,与1990年相比增长了1.46%,男性和女性分别增长了1.75%和1.07%。APC模型结果显示,1990—2019年男性和女性死亡风险均随年龄的增长而增加;随时期的推移呈现先下降后上升再下降的趋势;出生越晚的男性死亡风险越高;出生越晚的女性死亡风险越低。结论 1990—2019年中国胆道癌死亡率呈上升趋势,老年人群和越晚出生的男性死亡风险较高,胆道癌的防治工作应加强关注高危人群。

关键词: 胆道癌, 死亡率, 年龄-时期-队列模型, 趋势

Abstract: Objective The Objective of this study was to analyze the effect of age-time-cohort model on long-term trend of biliary tract cancer mortality in China from 1990 to 2019,and to provide scientific basis for the prevention and control of biliary tract cancer.Methods Based on the Global burden of disease(GBD)mortality data of Chinese residents with biliary tract cancer aged 20-84 from 1990 to 2019,the age-time-cohort(APC)model was used to analyze age effects of period and cohort on changes in biliary tract cancer mortality.Results The mortality of biliary tract cancer in China showed an upward trend from 1990 to 2019.In 2019,the mortality rate increased to 2.42/100,000,and the mortality for men and women increased to 2.45/100,000 and 2.39/100,000,respectively.Compared with 1990,an increase was 1.46%,men and women increased by 1.75% and 1.07%,respectively.The results of the APC model showed that the risk of death increased with age in both men and women from 1990 to 2019.The mortality first decreased,then increased and then decreased with the passage of time;men born later were at higher risk of death and women born later at lower risk of death.Conclusion The mortality of biliary tract cancer in China from 1990 to 2019 showed an upward trend.Elderly and men born later were at higher risk of death.The prevention and treatment of biliary tract cancer should pay more attention high-risk groups.

Key words: Biliary tract cancer, Mortality, Age-period-cohort model, Trend

中图分类号:

R735.8

刘春勋, 王鹏, 赵浩然, 张玉宝. 基于年龄-时期-队列模型分析1990—2019年中国胆道癌死亡趋势的研究[J]. 实用肿瘤学杂志, 2022, 36(4): 299-303.

LIU Chunxun, WANG Peng, ZHAO Haoran, ZHANG Yubao. Mortality trends of biliary tract cancer in China from 1990 to 2019 based on an age-period-cohort model[J]. Journal of Practical Oncology, 2022, 36(4): 299-303.

0
/ / 推荐

导出引用管理器 EndNote|Reference Manager|ProCite|BibTeX|RefWorks

链接本文: http://journal09.magtechjournal.com/Jwk3_syzlxzz/CN/10.11904/j.issn.1002-3070.2022.04.002

http://journal09.magtechjournal.com/Jwk3_syzlxzz/CN/Y2022/V36/I4/299

参考文献

1 Ackson SS,Dyke A,Zhu B,et al.Anthropometric risk factors for cancers of the biliary tract in the biliary tract cancers pooling project[J].Cancer Res,2019,79(15):459.
2 Bray F,Ferlay J,Soerjomataram I,et al.GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2018,68(6):394-424.
3 Tariq N,Mcnamara MG,Valle J.Biliary tract cancers:current knowledge,clinical candidates and future challenges[J].Cancer Manag Res,2019,11(2019):2623-2642.
4 Hung HY,Wang CC,Wei CC.Letter to the Editor:Postdiagnosis aspirin use associated with decreased biliary tract cancer[J].Hepatology,2021,74(4):1994-2006.
5 Zhang Y,Yang C,Huang M.Global,regional,and national burden of biliary tract cancer from 1990 to 2017 based on the 2017 Global burden of disease study[J].Cancer Epidemiol,2021,73(15):101949.
6 Torre LA,Siegel RL,Islami F,et al.Worldwide burden of and trends in mortality from gallbladder and other biliary tract cancers[J].Clin Gastroenterol Hepatol,2018,16(3):427-437.
7 Wu S,Zhao R,Zhuang Q,et al.Disease burden of primary gallbladder and biliary tract cancers associated with body mass index in 195 countries and territories,1990-2017:a systematic analysis for the global burden of disease study 2017[J].J Dig Dis,2022,23(3):157-165.
8 GBD 2019 Risk Factors Collaborators.Global burden of 87 risk factors in 204 countries and territories,1990-2019:a systematic analysis for the global burden of disease study 2019[J].Lancet,2020,396(10258):1223-1249.
9 GBD 2019 Diseases and Injuries Collaborators.Global burden of 369 diseases and injuries in 204 countries and territories,1990-2019:a systematic analysis for the global burden of disease study 2019[J].Lancet,2020,396(10258):1204-1222.
10 Iorio R.The future is here:bundled payments and international statistical classification of diseases,10th revision[J].J Arthroplasty,2016,31(5):931.
11 苏晶晶,彭非.年龄-时期-队列模型参数估计方法最新研究进展[J].统计与决策,2014,23(24):21-26.
12 Rosenberg PS,Check DP,Anderson WF.A web tool for age-period-cohort analysis of cancer incidence and mortality rates.[J].Cancer Epidemiol Biomarkers Prev,2014,23(11):2296-2302.
13 Singham J,Schaeffer D,Yoshida E,et al.Choledochal cysts:analysis of disease pattern and optimal treatment in adult and paediatric patients[J].HPB,2007,9(5):383-387.
14 Valle JW,Lamarca A,Goyal L,et al.New horizons for precision medicine in biliary tract cancers[J].Cancer Discovery,2017,7(9):943-962.
15 Hsieh RJ,Huang CP,Lu SN,et al.Postdiagnosis aspirin use associated with decreased biliary tract cancer-specific mortality in a large nationwide cohort[J].Hepatology,2021,74(4):1994-2006.
16 Ofoeyeno N,Ekpenyong E,Braconi C,et al.Pathogenetic role and clinical implications of regulatory rnas in biliary tract cancer[J].Cancers(Basel),2020,13(1):12.
17 Li Y,Teng D,Shi X,et al.Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the American Diabetes Association:national cross sectional study[J].BMJ,2020,28(369):997.
18 Larsson SC,Giovannucci EL,Wolk A.Prospective study of glycemic load,glycemic index,and carbohydrate intake in relation to risk of biliary tract cancer[J].Am J Gastroenterol,2016,111(6):891-896.
19 项鑫,王乙.中国人口老龄化现状、特点、原因及对策[J].中国老年学杂志,2021,41(18):4149-4152.
20 Pandey M,Shukla VK.Diet and gallbladder cancer:A case-control study[J].Eur J Cancer Prev,2002,11(4):365-368.
21 Baiu I,Visser B.Endoscopic retrograde cholangiopancreatography[J].JAMA,2018,320(19):2050.
22 Brunt LM,Deziel DJ,Telem DA,et al.Safe cholecystectomy multi-society practice guideline and state of the art consensus conference on prevention of bile duct injury during cholecystectomy[J].Ann Surg,2020,272(1):3-23.
23 Brandi G,Tavolari S.Asbestos and intrahepatic cholangiocarcinoma[J].Cells,2020,9(2):421.
24 Farioli A,Straif K,Brandi G,et al.Occupational exposure to asbestos and risk of cholangiocarcinoma:a population-based case-control study in four Nordic countries[J].Occup Environ Med,2018,75(3):191-198.
25 Lee MH,Gao YT,Huang YH,et al.A Metallomic approach to assess associations of serum metal levels with gallstones and gallbladder cancer[J].Hepatology,2020,71(3):917-928.
26 Lin Y,Nishiyama T,Kurosawa M,et al.Association between shift work and the risk of death from biliary tract cancer in Japanese men[J].BMC Cancer,2015,15(1):757.
27 王永斌,马石头,王焕,等.我国妇女生育水平变化及未来人口预测[J].中国卫生统计,2017,34(1):34-36.
28 Lohman E,Bitter TD,Verhoeven R,et al.Trends in treatment and survival of gallbladder cancer in the netherlands;identifying gaps and opportunities from a nation-wide cohort[J].Cancers,2020,12(4):918.

[1]	李鑫林, 周金意, 韩仁强, 蔡波, 徐红, 韩颖颖. 2013—2017年南通市肺癌流行病学特征分析[J]. 实用肿瘤学杂志, 2022, 36(4): 304-309.
[2]	王艳平, 邱琳, 武萌, 飒日娜. 2016年陕西省恶性肿瘤发病与死亡分析[J]. 实用肿瘤学杂志, 2022, 36(1): 1-6.
[3]	刘芮, 陈杨, 石青萍, 余秋丽, 朱云芳, 文洪梅. 云南省肿瘤登记地区2012—2016年甲状腺癌发病与死亡特征及时间趋势[J]. 实用肿瘤学杂志, 2021, 35(6): 489-494.
[4]	符艳, 颜李丽, 王春雨, 符芳敏, 董华. 2010—2016年琼海市恶性肿瘤流行情况分析[J]. 实用肿瘤学杂志, 2021, 35(5): 396-401.
[5]	刘言玉, 李道娟, 梁迪, 师金, 靳晶, 单保恩, 贺宇彤. 2011—2016年河北省肿瘤登记地区食管癌发病和死亡流行情况分析[J]. 实用肿瘤学杂志, 2021, 35(4): 314-320.
[6]	王秦, 林玲, 蔡波, 陶长余, 武鸣, 韩仁强, 罗鹏飞, 俞浩, 缪伟刚, 周金意. 2015年江苏省脑和神经系统肿瘤流行现状及2006—2015年趋势分析[J]. 实用肿瘤学杂志, 2021, 35(4): 321-326.
[7]	任思颖, 陈杨, 石青萍, 朱云芳, 文洪梅. 云南省肿瘤登记地区2011—2016年肺癌发病和死亡特征及时间趋势[J]. 实用肿瘤学杂志, 2021, 35(4): 332-338.
[8]	董华, 王定彬, 华婧, 范康琼, 马楠楠, 王兴任. 2016年海南省肿瘤登记地区恶性肿瘤发病与死亡分析[J]. 实用肿瘤学杂志, 2021, 35(4): 344-350.
[9]	刘慧敏, 乔丽颖, 钱永刚, 席云峰. 内蒙古2016年食管癌发病和死亡现状及2012—2016年趋势分析[J]. 实用肿瘤学杂志, 2021, 35(4): 351-356.
[10]	黄瑜, 刘玉琴, 丁高恒, 古扎努尔·尼牙孜, 王亮亮, 吴建军. 2009—2015年甘肃省肿瘤登记地区胆囊癌流行特征及变化趋势分析[J]. 实用肿瘤学杂志, 2021, 35(3): 193-199.
[11]	王亮亮, 丁高恒, 陈莉莉, 吴建军, 刘玉琴, 魏兴民. 2009—2015年甘肃省肿瘤登记地区胰腺癌流行特征及变化趋势分析[J]. 实用肿瘤学杂志, 2021, 35(3): 200-206.
[12]	郭伟, 朱奕潼, 丁高恒, 朱公建, 刘玉琴, 吴建军. 2009—2015年甘肃省肿瘤登记地区子宫体癌发病与死亡特征分析[J]. 实用肿瘤学杂志, 2021, 35(3): 207-211.
[13]	朱公建, 朱奕潼, 丁高恒, 王宏宗, 杜美霞, 刘玉琴. 2009—2015年甘肃省肿瘤登记地区结直肠癌流性特征及变化趋势分析[J]. 实用肿瘤学杂志, 2021, 35(3): 212-217.
[14]	张光耀, 郭伟, 朱奕潼, 丁高恒, 朱公建, 吴建军, 刘玉琴. 2009—2015年甘肃省肿瘤登记地区甲状腺癌流行特征及变化趋势[J]. 实用肿瘤学杂志, 2021, 35(3): 218-223.
[15]	姚丽萍, 王宏宗, 丁高恒, 刘玉琴. 2009—2015年甘肃省肿瘤登记地区宫颈癌流行特征及变化趋势分析[J]. 实用肿瘤学杂志, 2021, 35(3): 224-230.